AI-washing – when AI hype becomes a litigation risk
David Amar
Associate Global Regulatory
Languages
English, French, Hebrew
He advises clients in the pharmaceutical and medical device sectors on market access matters, including pricing, reimbursement, and early access pathways.
David also assists clients with tax and social security matters and represents them in disputes concerning the financial aspects of healthcare product sales, including contributions on sales and safeguard clauses.